Read More Pharma Industry News BrightPath Bio, Cellistic join forces to advance iPSC-derived CAR-NKT cell therapy for multiple myeloma BrightPath Bio and Cellistic have entered into a collaboration aimed at advancing iPSC-derived CAR-NKT cell therapy. This partnership… byPallavi MadhirajuDecember 15, 2024